期刊文献+

紫杉醇腹腔灌注化疗应用在晚期卵巢癌患者治疗中的临床效果研究

下载PDF
导出
摘要 目的了解晚期卵巢癌专业救治中展开紫杉醇腹腔灌注化学治疗疗法的有效性。方法通过筛选77例卵巢癌患者于2014年04月-2016年07月入住我院的晚期患者,参照不同化疗疗法的差异分组:展开全身静脉化学治疗疗法的38例属甲组,而展开紫杉醇腹腔灌注化学治疗疗法的39例属乙组,通过统计两组化疗质量,并作比较。结果甲组38例有效率50.00%,乙组39例76.92%,差异有统计学意义(P〈0.05)。结论当卵巢癌患者病情已达到晚期阶段时,通过展开腹腔灌注化学治疗疗法,同时合理用药紫杉醇,可充分改善病情,推荐选用。
作者 赵凤杰
出处 《实用妇科内分泌电子杂志》 2016年第16期49-50,共2页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献3

二级参考文献41

  • 1Pecorelli S, Favalli G, Gadducci A, et al. Phase m trim of observa- tion versus six courses of paclitaxel in patients with advanced epithelial o- varian cancer in complete response after six courses of paclitaxel/plati- num- based chemotherapy: final results of the after-6 protocol 1 [J]. J Clin Oncol, 2009, 27 (28) : 4642 -4648.
  • 2Hurt JD, Richardson DL, Seamon LG, et al. Sustained progression - free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer [J]. Gynecol Oncol, 2009, 115 (3): 396-400.
  • 3Green H, Soderkvist P, Rosenberg P, et al. Pharmacogenetic studies of paclitaxel in the treatment of ovarian cancer [ J]. Basic Clin Pharma- col Toxicol, 2009, 104 (2): 130-137.
  • 4Pectasides D, Xiros N, Papaxoinis G, et al. Gemcitabine and pegylat- ed liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel - pretreated, ovarian carci- noma [J]. Gynecol Oncol, 2008, 108 (1): 47-52.
  • 5Bianchi R, Buyukakilli B, Brines M, et al. Erythropoietin both pro- teets from and reverses experimental diabetic neuropathy [ J]. Proc Natl Acad Sci USA, 2004, 101 (3) : 823 -828.
  • 6Le T, Hopkins L, Baines KA, et al. Prospective evaluations of contin- uous weekly paclitaxel regimen in recurrent platinum - resistant epithelial ovarian cancer [J]. Gynecol Oncol, 2006, 102 (1) : 49 -53.
  • 7Bell J, Brady MF, Young RC, et al. Randomized phase iii trial of three versus six cycles of adjuvant.carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a gynecologic oncology group study [J]. Gynecol Oncol, 2006, 102 (3) : 432 -439.
  • 8Vasey PA, Jayson GC, Gordon A, et al. Phase iii randomized trial of docetaxel- carboplatin versus paclitaxel -carboplatin as first- line chemotherapy for ovarian carcinoma [ J ]. J Natl Cancer Inst, 2004, 96 (22): 1682 -1691.
  • 9Doi D, Ota Y, Konishi H, et al. Evaluation of the neurotoxicity of pa- clitaxel and carboplatin by current perception threshold in ovarian cancer patients [J]. J Nippon Med Sch, 2003, 70 (2) : 129 -134.
  • 10Xiao WH, Bennett GJ. Chemotherapy - evoked neuropathic pain : ab- normal spontaneous dischargd in a - fiber and c - fiber primary afferent neurons and its suppression by acetyl - L - carnitine [ J :. Pain, 2008, 135 (3): 262-270.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部